{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:19:47Z","timestamp":1792030787365,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd012346","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T00:00:00Z","timestamp":1545177600000}}],"reference-count":130,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012346.pub2","type":"journal-article","created":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T15:19:14Z","timestamp":1545232754000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease"],"prefix":"10.1002","volume":"2018","author":[{"given":"Justyna","family":"Pollok","sequence":"first","affiliation":[{"name":"The University of Adelaide; Faculty of Health and Medical Sciences; North Terrace Adelaide South Australia Australia 5005"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joep EM","family":"van Agteren","sequence":"additional","affiliation":[{"name":"Flinders University; College of Medicine and Public Health; Adelaide Australia"},{"name":"South Australian Health and Medical Research Institute; Wellbeing and Resilience Centre; Adelaide Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin V","family":"Carson-Chahhoud","sequence":"additional","affiliation":[{"name":"The University of South Australia; School of Health Sciences; City East Campus, Frome Road Adelaide Australia 5001"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,12,19]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD012346.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S0033-3182(92)71995-1","article-title":"Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease","volume":"33","author":"Borson","year":"1992","journal-title":"Psychosomatics"},{"issue":"2","key":"10.1002\/14651858.CD012346.pub2-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1081\/COPD-57596","article-title":"Effect of treating depression on quality-of-life and exercise tolerance in severe COPD","volume":"2","author":"Eiser","year":"2005","journal-title":"COPD: Journal of Chronic Obstructive Pulmonary Disease"},{"issue":"3","key":"10.1002\/14651858.CD012346.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/crj.12219","article-title":"Sertraline hydrochloride treatment for patients with stable chronic obstructive pulmonary disease complicated with depression: a randomized controlled trial","volume":"10","author":"He","year":"2016","journal-title":"The Clinical Respiratory Journal"},{"issue":"3","key":"10.1002\/14651858.CD012346.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.4081\/monaldi.2004.692","article-title":"Randomized trial of paroxetine in end-stage COPD","volume":"61","author":"Lacasse","year":"2004","journal-title":"Monaldi Archives for Chest Disease"},{"issue":"1","key":"10.1002\/14651858.CD012346.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0165-1781(85)90036-8","article-title":"Effect of desipramine on control of ventilation and depression scores in patients with severe chronic obstructive pulmonary disease","volume":"15","author":"Gordon","year":"1985","journal-title":"Psychiatry Research"},{"issue":"7","key":"10.1002\/14651858.CD012346.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1001\/archinte.1986.00360190155022","article-title":"Doxepin treatment of depressed patients with chronic obstructive pulmonary disease","volume":"146","author":"Light","year":"1986","journal-title":"Archives of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012346.pub2-BIB0007|cit7","first-page":"588","article-title":"Comprehensive patterns of comorbidity: COPD and depression. Aspects of treatment","volume":"71","author":"Moisieieva","year":"2018","journal-title":"Wiadomosci Lekarskie"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejcdt.2014.08.006","article-title":"Effect of treatment of depression and anxiety on physiological state of severe COPD patients","volume":"64","author":"Momtaz","year":"2015","journal-title":"Egyptian Journal of Chest Disease and Tuberculosis"},{"issue":"3","key":"10.1002\/14651858.CD012346.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1378\/chest.103.3.800","article-title":"Effects of buspirone on anxiety levels and exercise tolerance in patients with chronic airflow obstruction and mild anxiety","volume":"103","author":"Singh","year":"1993","journal-title":"Chest"},{"issue":"3","key":"10.1002\/14651858.CD012346.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1183\/09031936.95.08030425","article-title":"Effect of protriptyline, 10 mg daily, on chronic hypoxaemia in chronic obstructive pulmonary disease","volume":"8","author":"Strom","year":"1995","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0011|cit11","unstructured":"Subbe C Collier G Bedson E Meknkes D Effect of citalopram on health status, anxiety and depression in patients with chronic obstructive pulmonary disease: a pilot study trial protocol"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0012|cit12","unstructured":"Subbe C Collier G Bedson E Menkes D Pilot study to examine the effect of citalopram on health status, anxiety and depression in patients with chronic obstructive pulmonary disease unpublished data"},{"issue":"5","key":"10.1002\/14651858.CD012346.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/gps.461","article-title":"A feasibility study of antidepressant drug therapy in depressed elderly patients with chronic obstructive pulmonary disease","volume":"16","author":"Yohannes","year":"2001","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0014|cit14","unstructured":"Mathews AM Kuehn H Safety of anti-depressant for Chronic Obstructive Pulmonary Disease (SAD-COPD) ClinicalTrials.gov NCT02813447"},{"issue":"5","key":"10.1002\/14651858.CD012346.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"441-9","DOI":"10.1016\/j.psym.2011.03.005","article-title":"Acute exacerbations of chronic obstructive pulmonary disease and the effect of existing psychiatric comorbidity on subsequent mortality","volume":"52","author":"Abrams","year":"2011","journal-title":"Psychosomatics"},{"issue":"7230","key":"10.1002\/14651858.CD012346.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/457675a","article-title":"Neuroscience: glia - more than just brain glue","volume":"457","author":"Allen","year":"2009","journal-title":"Nature"},{"issue":"5","key":"10.1002\/14651858.CD012346.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1441-8","DOI":"10.1378\/chest.121.5.1441","article-title":"Mortality after hospitalization for COPD","volume":"121","author":"Almagro","year":"2002","journal-title":"Chest"},{"issue":"1","key":"10.1002\/14651858.CD012346.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-0327(99)00092-0","article-title":"Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability","volume":"58","author":"Anderson","year":"2000","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0019|cit19","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2000"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0020|cit20","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"issue":"3","key":"10.1002\/14651858.CD012346.pub2-BIB0021|cit21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007954","article-title":"Antidepressants versus placebo for depression in primary care: review","author":"Arroll","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012346.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1378\/chest.12-1911","article-title":"Biodirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis","volume":"144","author":"Atlantis","year":"2013","journal-title":"Chest"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","author":"American Thoracic Society","year":"2002","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s11136-013-0515-5","article-title":"Demographic and clinical characteristics associated with quality of life in patients with chronic obstructive pulmonary disease","volume":"23","author":"Bentsen","year":"2014","journal-title":"Quality of Life Research"},{"issue":"2","key":"10.1002\/14651858.CD012346.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.tips.2006.12.005","article-title":"GDNF family receptor complexes are emerging drug targets","volume":"28","author":"Bespalov","year":"2007","journal-title":"Trends in pharmacological sciences"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0027|cit27","volume-title":"Lost in Translation: Bridging the Communication Gap in COPD: a Report by the British Lung Foundation","author":"British Lung Foundation","year":"2006"},{"issue":"5","key":"10.1002\/14651858.CD012346.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1249\/00005768-198205000-00012","article-title":"Psychophysical basis of perceived exertion","volume":"14","author":"Borg","year":"1982","journal-title":"Medicine and Science in Sports and Exercise"},{"issue":"6329","key":"10.1002\/14651858.CD012346.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1136\/bmj.284.6329.1607","article-title":"Two-, six-, and 12-minute walking tests in respiratory disease","volume":"284","author":"Butland","year":"1982","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1440-1843.2012.02148.x","article-title":"Treatments for anxiety and depression in patients with chronic obstructive pulmonary disease: a literature review","volume":"17","author":"Cafarella","year":"2012","journal-title":"Respirology"},{"issue":"1","key":"10.1002\/14651858.CD012346.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/135581960000500105","article-title":"Sample size calculations for cluster randomised trials. Changing professional practice in Europe Group (EU BIOMED II Concerted Action)","volume":"5","author":"Campbell","year":"2000","journal-title":"Journal of Health Services Research and Policy"},{"issue":"3","key":"10.1002\/14651858.CD012346.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10729-014-9316-9","article-title":"The cost of hospital readmissions: evidence from the VA","volume":"19","author":"Carey","year":"2016","journal-title":"Health Care Management Science"},{"issue":"3","key":"10.1002\/14651858.CD012346.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jpsychores.2011.06.008","article-title":"Latent structure of the Hospital Anxiety and Depression Scale: A 10-year systematic review","volume":"72","author":"Cosco","year":"2012","journal-title":"Journal of Psychosomatic Research"},{"issue":"4","key":"10.1002\/14651858.CD012346.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"e60532","DOI":"10.1371\/journal.pone.0060532","article-title":"The effect of complex interventions on depression and anxiety in chronic obstructive pulmonary disease: systematic review and meta-analysis","volume":"8","author":"Coventry","year":"2013","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1002\/14651858.CD012346.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1176\/appi.psy.47.4.312","article-title":"Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression","volume":"47","author":"Cully","year":"2006","journal-title":"Psychosomatics"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/15412555.2011.586659","article-title":"Clinical and economic burden of depression\/anxiety in chronic obstructive pulmonary disease patients within a managed care population","volume":"8","author":"Dalal","year":"2011","journal-title":"COPD: Journal of Chronic Obstructive Pulmonary Disease"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0037|cit37","first-page":"1154","article-title":"A randomised controlled trial of the effect of psychotherapy on anxiety and depression in chronic obstructive pulmonary disease","volume":"84","author":"Godoy","year":"2003","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"issue":"3","key":"10.1002\/14651858.CD012346.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"619-25","DOI":"10.1378\/chest.08-0078","article-title":"Depressive symptoms as predictors of mortality in patients with COPD","volume":"135","author":"Voogd","year":"2009","journal-title":"Chest Journal"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0039|cit39","unstructured":"Deeks JJ Higgins JP Altman DG editor(s) on behalf of the Cochrane Statistical Methods Group Chapter 9: Analysing data and undertaking metaanalyses. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). Cochrane, 2017 Available from handbook.cochrane.org"},{"issue":"16","key":"10.1002\/14651858.CD012346.pub2-BIB0040|cit40","first-page":"1","article-title":"Patient experiences of depression and anxiety with chronic disease: a systematic review and qualitative meta-synthesis","volume":"13","author":"DeJean","year":"2013","journal-title":"Health Quality Ontario"},{"issue":"10","key":"10.1002\/14651858.CD012346.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.rmed.2006.01.026","article-title":"Anxiety and depression in COPD patients: the roles of gender and disease severity","volume":"100","author":"Marco","year":"2006","journal-title":"Respiratory Medicine"},{"issue":"2","key":"10.1002\/14651858.CD012346.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jpsychores.2012.09.022","article-title":"The role of social support in anxiety for persons with COPD","volume":"74","author":"Dinicola","year":"2013","journal-title":"Journal of Psychosomatic Research"},{"issue":"7109","key":"10.1002\/14651858.CD012346.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/(SICI)1099-1166(199708)12:8<817::AID-GPS645>3.0.CO;2-4","article-title":"Placebo-controlled treatment trial of depression in elderly physically ill patients","volume":"12","author":"Evans","year":"1997","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"21","key":"10.1002\/14651858.CD012346.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"2345-53","DOI":"10.1001\/archinte.167.21.2345","article-title":"Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease","volume":"167","author":"Fan","year":"2007","journal-title":"Archives of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012346.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"PCC.09m00858","DOI":"10.4088\/PCC.09m00858gry","article-title":"Added burden of mental disorders on health status among patients with chronic obstructive pulmonary disease","volume":"12","author":"Felker","year":"2010","journal-title":"Primary Care Companion to the Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD012346.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4088\/PCC.v03n0105","article-title":"SSRI antidepressant medications: adverse effects and tolerability","volume":"3","author":"Ferguson","year":"2001","journal-title":"Primary Care Companion to the Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0048|cit48","first-page":"1321","article-title":"Prevalence and correlates of suicide ideation in patients with COPD: a mixed methods study","volume":"10","author":"Fleehart","year":"2014","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"issue":"6","key":"10.1002\/14651858.CD012346.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/jama.288.6.701","article-title":"Sertraline treatment of major depression in patients with acute MI or unstable angina","volume":"288","author":"Glassman","year":"2002","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0050|cit50","unstructured":"Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Global Initiative for Chronic Obstructive Lung Disease; Revised 2018 www.goldcopd.org\/wp-content\/uploads\/2017\/11\/GOLD-2018-v6.0-FINAL-revised-20-Nov_WMS.pdf 1 142"},{"issue":"2","key":"10.1002\/14651858.CD012346.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/ntr\/ntr165","article-title":"Depression, anxiety and COPD: the unexamined role of nicotine dependence","volume":"14","author":"Goodwin","year":"2012","journal-title":"Nicotine and Tobacco Research"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0052|cit52","unstructured":"GRADE Working Group GRADEpro GDT 2015"},{"issue":"2","key":"10.1002\/14651858.CD012346.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"459-67","DOI":"10.1378\/chest.124.2.459","article-title":"Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD","volume":"124","author":"Groenewegen","year":"2003","journal-title":"Chest"},{"issue":"3","key":"10.1002\/14651858.CD012346.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1183\/09031936.05.00078504","article-title":"Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression","volume":"26","author":"Gudmundsson","year":"2005","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"604-11","DOI":"10.1164\/rccm.201003-0472OC","article-title":"Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort","volume":"183","author":"Hanania","year":"2011","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"d4660","DOI":"10.1136\/bmj.d4660","article-title":"Antidepressants in elderly people","volume":"343","author":"Hickie","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0058|cit58","unstructured":"Higgins JP Deeks JJ Altman DG on behalf of the Cochrane Statistical Methods Group Green S (editors) Chapter 16: Special topics in statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0059|cit59","unstructured":"Higgins JPT Altman DG Sterne JAC editor(s) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). Cochrane, 2017. Available from handbook.cochrane.org"},{"issue":"22","key":"10.1002\/14651858.CD012346.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"13678","DOI":"10.1074\/jbc.M114.622415","article-title":"Tricyclic antidepressant amitriptyline-induced glial cell line-derived neurotrophic factor production involves pertussis toxin-sensitive g\u03b1i\/o activation in astroglial cells","volume":"290","author":"Hisaoka-Nakashima","year":"2015","journal-title":"Journal of Biological Chemistry"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"14076","DOI":"10.1038\/npjpcrm.2014.76","article-title":"'The COPD breathlessness manual': a randomised controlled trial to test a cognitive-behavioural manual versus information booklets on health service use, mood and health status, in patients with chronic obstructive pulmonary disease","volume":"24","author":"Howard","year":"2014","journal-title":"Primary Care Respiratory Medicine"},{"issue":"12","key":"10.1002\/14651858.CD012346.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1007\/s00125-010-1873-y","article-title":"Health care costs in patients with diabetes mellitus and comorbid mental disorders - a systematic review","volume":"53","author":"Hutter","year":"2010","journal-title":"Diabetologia"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.rmed.2010.02.020","article-title":"A randomised controlled trial of cognitive behavioral therapy for anxiety and depression in COPD","volume":"104","author":"Hynninen","year":"2010","journal-title":"Respiratory Medicine"},{"issue":"Suppl B","key":"10.1002\/14651858.CD012346.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0954-6111(06)80166-6","article-title":"The St George's Respiratory Questionnaire","volume":"85","author":"Jones","year":"1991","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1176\/ajp.147.2.200","article-title":"The prevalence of anxiety disorders in patients with chronic obstructive pulmonary disease","volume":"147","author":"Karajgi","year":"1990","journal-title":"American Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD012346.pub2-BIB0066|cit66","first-page":"617-27","article-title":"Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Archives of General Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD012346.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1176\/appi.psy.41.6.465","article-title":"Functional impairment in COPD patients: the impact of anxiety and depression","volume":"41","author":"Kim","year":"2000","journal-title":"Psychosomatics"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00408-013-9547-4","article-title":"Association of depression with disease severity in patients with chronic obstructive pulmonary disease","volume":"192","author":"Kim","year":"2014","journal-title":"Lung"},{"issue":"4","key":"10.1002\/14651858.CD012346.pub2-BIB0069|cit69","first-page":"1205","article-title":"Surprisingly high prevalence of anxiety and depression in chronic breathing disorders","volume":"127","author":"Kunik","year":"2005","journal-title":"Chest"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1017\/S0033291707001687","article-title":"COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomised controlled trial","volume":"38","author":"Kunik","year":"2008","journal-title":"Psychological Medicine"},{"issue":"5","key":"10.1002\/14651858.CD012346.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3109\/15412555.2010.510156","article-title":"Improving quality of life in depressed COPD patients: effectiveness of a minimal psychological intervention","volume":"7","author":"Lamers","year":"2010","journal-title":"COPD: Journal of Chronic Obstructive Pulmonary Disease"},{"issue":"4","key":"10.1002\/14651858.CD012346.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1378\/chest.10-1253","article-title":"COPD in never smokers. Results from the population-based burden of obstructive lung disease study","volume":"139","author":"Lamprecht","year":"2011","journal-title":"Chest"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1183\/16000617.0026-2017","article-title":"The frequent and underrecognised co-occurrence of acute exacerbated COPD and depression warrants screening: a systematic review","volume":"26","author":"Lecheler","year":"2017","journal-title":"European Respiratory Review"},{"issue":"3","key":"10.1002\/14651858.CD012346.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/ageing\/afu201","article-title":"The effect of nurse-led problem-solving therapy on coping, self-efficacy and depressive symptoms for patients with chronic obstructive pulmonary disease: a randomised controlled trial","volume":"44","author":"Lee","year":"2015","journal-title":"Age and Ageing"},{"issue":"2","key":"10.1002\/14651858.CD012346.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1183\/09031936.06.00025805","article-title":"Chronic obstructive pulmonary disease: current burden and future projections","volume":"27","author":"Lopez","year":"2006","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0076|cit76","volume-title":"Manual for Depression Anxiety Stress Scales","author":"Lovibond","year":"1995"},{"issue":"2","key":"10.1002\/14651858.CD012346.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1155\/2011\/745047","article-title":"Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline","volume":"18","author":"Marciniuk","year":"2011","journal-title":"Canadian Respiratory Journal"},{"issue":"7","key":"10.1002\/14651858.CD012346.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jclinepi.2013.01.010","article-title":"Minimum clinically important differences identified for commonly used depression rating scales","volume":"66","author":"Masson","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"11","key":"10.1002\/14651858.CD012346.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"43S","DOI":"10.1378\/chest.08-0342","article-title":"Anxiety and depression in COPD: current understanding, unanswered questions, and research needs","volume":"134","author":"Maurer","year":"2008","journal-title":"Chest"},{"issue":"6","key":"10.1002\/14651858.CD012346.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4088\/JCP.12r07757","article-title":"Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review","volume":"74","author":"McHugh","year":"2013","journal-title":"Journal of Clinical Psychiatry"},{"issue":"593","key":"10.1002\/14651858.CD012346.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"e808","DOI":"10.3399\/bjgp11X613151","article-title":"Case identification of depression in patients with chronic physical health problems: a diagnostic accuracy meta-analysis of 113 studies","volume":"61","author":"Meader","year":"2011","journal-title":"British Journal of General Practice"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2174\/157339812799859743","article-title":"Depression and anxiety in patients with COPD: a focus on psychological treatments in ambulatory care settings","volume":"8","author":"Mignogna","year":"2012","journal-title":"Current Respiratory Medicine Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012346.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/08039480310000824","article-title":"Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review","volume":"58","author":"Mikkelsen","year":"2004","journal-title":"Nordic Journal of Psychiatry"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00408-014-9557-x","article-title":"Factors associated with a low level of physical activity in patients with chronic obstructive pulmonary disease","volume":"192","author":"Miravitlles","year":"2014","journal-title":"Lung"},{"issue":"8","key":"10.1002\/14651858.CD012346.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1177\/0269881108093582","article-title":"Problems associated with long-term treatment with selective serotonin reuptake inhibitors","volume":"23","author":"Moret","year":"2009","journal-title":"Journal of Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD012346.pub2-BIB0087|cit87","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003491","article-title":"Antidepressants for depressed elderly","author":"Mottram","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0088|cit88","unstructured":"Naylor C Parsonage M McDaid D Knapp M Fossey M Galea A The Kings Fund and Centre for Mental Health Long-term conditions and mental health. The cost of co-morbidities kingsfund.org.uk\/publications\/long-term-conditions-and-mental-health 1 32"},{"issue":"1","key":"10.1002\/14651858.CD012346.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/archinte.167.1.60","article-title":"Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life","volume":"167","author":"Ng","year":"2007","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.rmed.2008.12.010","article-title":"Co-morbid association of depression and COPD: a population-based study","volume":"103","author":"Ng","year":"2009","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0091|cit91","unstructured":"National Institute for Health and Clinical Excellence CG91 Depression with a chronic physical health problem: NICE guideline National Collaborating Centre for Mental Health. London, UK 2009"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0092|cit92","unstructured":"National Institute for Health and Clinical Excellence CG90 Depression: The treatment and management of depression in adults: NICE guideline (updated edition) National Collaborating Centre for Mental Health. London, UK 2010"},{"issue":"8","key":"10.1002\/14651858.CD012346.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"778.e9","DOI":"10.1016\/j.amjmed.2009.01.036","article-title":"Depression and health-related quality of life in chronic obstructive pulmonary disease","volume":"122","author":"Omachi","year":"2009","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0094|cit94","first-page":"1289","article-title":"Overview of the prevalence, impact, and management of depression and anxiety in chronic obstructive pulmonary disease","volume":"9","author":"Panagioti","year":"2014","journal-title":"International Journal of COPD"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1176\/ajp.152.10.1531a","article-title":"Sertraline for chronic obstructive pulmonary disease and comorbid anxiety and mood disorders","volume":"152","author":"Papp","year":"1995","journal-title":"American Journal of Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD012346.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.2105\/AJPH.88.10.1518","article-title":"Depression, anxiety, and smoking initiation: a prospective study over 3 years","volume":"88","author":"Patton","year":"1998","journal-title":"American Journal of Public Health"},{"issue":"2","key":"10.1002\/14651858.CD012346.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3109\/13814781003692463","article-title":"Guideline recommendations for long-term treatment of depression with antidepressants in primary care: a critical review","volume":"16","author":"Piek","year":"2010","journal-title":"European Journal of General Practice"},{"issue":"10","key":"10.1002\/14651858.CD012346.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"765","DOI":"10.7326\/0003-4819-136-10-200205210-00013","article-title":"Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force","volume":"136","author":"Pignone","year":"2002","journal-title":"Annals of Internal Medicine"},{"issue":"9","key":"10.1002\/14651858.CD012346.pub2-BIB0099|cit99","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012347","article-title":"Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease","author":"Pollok","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012346.pub2-BIB0100|cit100","first-page":"15","article-title":"Examining the relationship between anxiety and depression and exacerbations of COPD which result in hospital admission: a systematic review","volume":"9","author":"Pooler","year":"2014","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"issue":"11","key":"10.1002\/14651858.CD012346.pub2-BIB0101|cit101","first-page":"1615","article-title":"Anxiety and depression - important psychological comorbidities of COPD","volume":"6","author":"Pumar","year":"2014","journal-title":"Journal of Thoracic Disease"},{"issue":"6","key":"10.1002\/14651858.CD012346.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1164\/rccm.200703-456SO","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary","volume":"176","author":"Rabe","year":"2007","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"11","key":"10.1002\/14651858.CD012346.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.2174\/13894501113149990156","article-title":"Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue","volume":"14","author":"Rajkowska","year":"2013","journal-title":"Current Drug Targets"},{"issue":"3","key":"10.1002\/14651858.CD012346.pub2-BIB0104|cit104","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007503.pub2","article-title":"Antidepressants for depression in physically ill people","author":"Rayner","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012346.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0278-5846(88)90039-5","article-title":"Anticholinergic side effects of tricyclic antidepressants and their management","volume":"12","author":"Remick","year":"1988","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0106|cit106","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2165\/11316580-000000000-00000","article-title":"Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis","volume":"32","author":"Rief","year":"2009","journal-title":"Drug Safety"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0108|cit108","unstructured":"Ryan R Hill S How to GRADE the quality of the evidence Cochrane Consumers and Communication Review Group December 2016"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0109|cit109","volume-title":"Kaplan and Sadock's Comprehensive Textbook of Psychiatry","author":"Sadock","year":"2009"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0110|cit110","first-page":"52","article-title":"Serotonin activity in psychotic (delusional) major depression","volume":"53","author":"Schatzberg","year":"1992","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0111|cit111","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JP Deeks JJ Glasziou P on behalf of the Cochrane Applicability and Recommendations Methods Group Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjresp-2014-000042","article-title":"A review of the effectiveness of psychological interventions used for anxiety and depression in chronic obstructive pulmonary disease","volume":"1","author":"Smith","year":"2014","journal-title":"BMJ Open Respiratory Research"},{"issue":"1","key":"10.1002\/14651858.CD012346.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jpainsymman.2005.06.007","article-title":"A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease","volume":"31","author":"Solano","year":"2006","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/jama.282.18.1737","article-title":"Validity and utility of a self-report version of PRIME-MD: the PHQ Primary Care Study","volume":"282","author":"Spitzer","year":"1999","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD012346.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2147\/copd.2006.1.3.315","article-title":"Depression in COPD - management and quality of life considerations","volume":"1","author":"Stage","year":"2006","journal-title":"International Journal of COPD"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1192\/bjp.173.4.312","article-title":"Typology of common psychiatric syndromes. An empirical study","volume":"173","author":"Sullivan","year":"1998","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2147\/NDT.S79354","article-title":"Strategies to improve anxiety and depression in patients with COPD: a mental health perspective","volume":"12","author":"Tselebis","year":"2016","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"5","key":"10.1002\/14651858.CD012346.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/thorax.57.5.412","article-title":"Risk of depression in patients with chronic obstructive pulmonary disease and its determinants","volume":"57","author":"Manen","year":"2002","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"1800475","DOI":"10.1183\/13993003.00475-2018","article-title":"Serotonergic antidepressant use and morbidity and mortality among older adults with COPD","volume":"52","author":"Vozoris","year":"2018","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0120|cit120","volume-title":"SF-36 Health Survey: manual and interpretation guide","author":"Ware","year":"1993"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0121|cit121","unstructured":"World Health Organization COPD predicted to be the third leading cause of death in 2030 http:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/chronic-obstructive-pulmonary-disease-(copd)"},{"issue":"9","key":"10.1002\/14651858.CD012346.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.euroneuro.2011.07.018","article-title":"The size and burden of mental disorders and other disorders of the brain in Europe 2010","volume":"21","author":"Wittchen","year":"2011","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0123|cit123","volume-title":"The COPD-X Plan: Australian and New Zealand Guidelines for the Management of Chronic Obstructive Pulmonary Disease 2018. Version 2.53","author":"Yang","year":"March 2018"},{"issue":"19","key":"10.1002\/14651858.CD012346.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"e6836","DOI":"10.1097\/MD.0000000000006836","article-title":"Prevalence of comorbidities in chronic obstructive pulmonary disease patients","volume":"96","author":"Yin","year":"2017","journal-title":"Medicine"},{"key":"10.1002\/14651858.CD012346.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/ageing\/afi163","article-title":"Predictors of 1-year mortality in patients discharged from hospital following acute exacerbation of chronic obstructive pulmonary disease","volume":"34","author":"Yohannes","year":"2005","journal-title":"Age and Ageing"},{"issue":"3","key":"10.1002\/14651858.CD012346.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1586\/17476348.2.3.337","article-title":"Management of anxiety and depression in patients with COPD","volume":"2","author":"Yohannes","year":"2008","journal-title":"Expert Review of Respiratory Medicine"},{"issue":"6","key":"10.1002\/14651858.CD012346.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1586\/ers.11.70","article-title":"Do antidepressants work in patients with chronic obstructive pulmonary disease with comorbid depression?","volume":"5","author":"Yohannes","year":"2011","journal-title":"Expert Review of Respiratory Medicine"},{"issue":"7","key":"10.1002\/14651858.CD012346.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s40266-014-0186-0","article-title":"Pharmacologic treatment of depression in older patients with COPD: impact on the course of the disease and health outcomes","volume":"31","author":"Yohannes","year":"2014","journal-title":"Drugs & Aging"},{"issue":"3","key":"10.1002\/14651858.CD012346.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.genhosppsych.2011.03.009","article-title":"Prevalence of depressive symptoms in patients with chronic obstructive pulmonary disease: a systematic review, meta-analysis and meta-regression","volume":"33","author":"Zhang","year":"2011","journal-title":"General Hospital Psychiatry Journal"},{"issue":"9","key":"10.1002\/14651858.CD012346.pub2-BIB0130|cit130","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012346","article-title":"Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease","author":"Naqvi","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD012346.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T23:05:55Z","timestamp":1628550355000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD012346.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Common Mental Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,12,19]]},"references-count":130,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012346.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,19]]}}}